ACSL4 and mesothelioma: Studies have shown that YAP pathway activation in mesothelioma tissue enhances iron death sensitivity through ACSL4 and TFRC, and YAP, ACSL4, and TFRC are expected to be biological markers for clinical prediction of iron death sensitivity in mesothelioma [50].